US71742Q1067
US71742Q1067
Phibro Animal Health Corporatio
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.56B EUR | 1.27B EUR | 2.24B EUR | 1.51B EUR |
Enterprise Value | 2.23B EUR | 2B EUR | 2.98B EUR | 2.23B EUR |
Valuation Multiples | ||||
Trailing P/E | 15.76x | 12.77x | 23.56x | 21.27x |
Forward P/E | 9.97x | -- | -- | -- |
Price to Sales | 1.02x | 0.84x | 1.5x | 1.36x |
Price to Book | 4.03x | 3.3x | 6.2x | 4.56x |
EV/Revenue | 1.47x | 1.32x | 1.98x | 2x |
EV/EBITDA | 9.13x | 8.15x | 12.94x | 12.88x |
Price to FCF (P/FCF) | -- | 129.1x | 175.68x | 127.46x |
EV/FCF | -- | 202.83x | 233.04x | 187.87x |
FCF Yield | -1.24% | 0.77% | 0.57% | 0.78% |